In contrast, higher levels of AMP hydrolysis were observed in patients with stages IIB and III, suggesting that the coordinated action of CD39/CD73, phosphodiesterase, and alkaline phosphatase can modulate the immune system, creating a favorable environment for tumor development (10). The gene discussed is ENTPD1; the disease is neoplasm.